Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised…

By S. Connolly, Janice Pogue, R. Hart, M. Pfeffer, S. Hohnloser, S. Chrolavicius, S. Yusuf. The Lancet, 2006

1,960 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Neurology

View Paper: https://www.semanticscholar.org/paper/af24ac1be3aeae2626f91bea40ba798c2ae04148

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. Gerhard Hindricks
3. T. Horwich
4. Gregory Y. H. Lip
5. A. Goette
6. Paulus Kirchhof
7. Ulrich Schotten
8. J. Januzzi

Citations in the corpus

• The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. (2018, background): “only ACS) and elevated bleeding risk, one could opt to treat with DAPT only, without anticoagulants, from the onset.(307)”